This Tiny Early-Stage Biotech ETF Was Q1’s Best Performing Fund

From Zacks: After being stressed by the twin attacks of higher drug pricing and increased regulatory scrutiny, the biotech sector has made a strong comeback in the first quarter of 2017.
NASDAQ:BBC March 31, 2017 9:38am

BioShares Biotech Clinical Trials Fund, Up 5%, Is Today’s Top Performing ETF

The BioShares Biotechnology Clinical Trials Fund (BBC) outperformed all other non-leveraged, non-inverse exchange traded products in the U.S. today on a percentage basis, producing a +5.03% one-day return and outperforming the wider markets by a total of 5.04 percentage points.
NASDAQ:BBC January 31, 2017 5:42pm

BioShares Launches Two New Biotechnology ETFs

etfsLifeSci Index Partners, LLC (“LSIP”), a New York City-based investment advisor and index provider, today launched the BioShares™ Biotechnology Clinical Trials Fund (NASDAQ:BBC) and the BioShares™ Biotechnology Products Fund (NASDAQ:BBP) (together, “the Funds”). 
NASDAQ:BBC December 17, 2014 2:07pm

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories